Braveheart
48 employees on LinkedIn · 4 known investors
Find your way into Braveheart
Each arrow is one introduction. Sign up to fill in the first one.
Ask Carol Suh to introduce you to Travis Murdoch, M.D.
You →Carol · together at HI-Bio →Travis
Sign up to find every way you can get introduced to Braveheart
- Your email: who you already know at Braveheart, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Braveheart team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Braveheart develops treatments for hypertrophic cardiomyopathy and related cardiac conditions. The company focuses on improving the standard of care for patients with these disease types.
Founders & leadership

Investors · 4
How we know: a16z's portfolio · cryptobriefing.com · Not right? Tell us
How we know: Frazier Life Sciences's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: OrbiMed's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us
Funding
SEC filings, press & company announcementsSource: company announcements and press reports — follow each round's link for the claim.
Related companies · 4
Companies working in the same space as Braveheart.
Frequently asked questions
- What does Braveheart do?
- Braveheart develops treatments for hypertrophic cardiomyopathy and related cardiac conditions. The company focuses on improving the standard of care for patients with these disease types.
- Who are Braveheart's investors?
- Braveheart's investors include Andreessen Horowitz, Frazier Life Sciences, OrbiMed, Forbion.




